Summary

The North America gastrointestinal endoscopy market, is expected to reach USD 7,416,633.98 thousand by 2032 from USD 4,708,235.14 thousand in 2024, growing at a substantial CAGR of 5.9% in the forecast period of 2025 to 2032.
Market Segmentation:
North America Gastrointestinal Endoscopy Market, Product (Gastrointestinal Endoscopes & Systems and Gastrointestinal Endotherapy), Application (Treatment and Diagnosis), Procedure Type (Colonoscopy, Gastroscopy, Duodenoscopy, Enteroscopy, Sigmoidoscopy and Others), Usability (Reusable and Disposable/ Single Use), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Laboratories, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others), Country (U.S., Canada and Mexico) -Industry Trends & Forecast To 2032

Overview of the North America Gastrointestinal Endoscopy are:

Driver

• Rising Prevalence of Gastrointestinal Disorders

Restrain

• High Cost of Equipment and Procedures
Opportunity

• Growing Emphasis on Early Colorectal Cancer Detection

Market Players:

The key market players for North America Gastrointestinal Endoscopy are listed below:

• Medtronic (Ireland)
• Stryker (U.S.)
• Johnson & Johnson Services, Inc. (U.S.)
• Boston Scientific Corporation (U.S.)
• Cook (U.S.)
• CONMED Corporation (U.S.)
• STERIS (U.S.)
• Henry Schein, Inc. (U.S.)
• CapsoVision, Inc. (U.S.)
• Teleflex Incorporated (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• Olympus Corporation (Japan)
• Hoya Corporation (Japan)
• Smith+Nephew (UK)
• KLS Martin Group (Germany)
• Laborie (Canada)

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 INTRODUCTION 93
1.1 OBJECTIVES OF THE STUDY 93
1.2 MARKET DEFINITION 93
1.3 OVERVIEW OF THE NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET 93
1.4 LIMITATIONS 95
1.5 MARKETS COVERED 95
2 MARKET SEGMENTATION 98
2.1 MARKETS COVERED 98
2.2 GEOGRAPHICAL SCOPE 99
2.3 YEARS CONSIDERED FOR THE STUDY 100
2.4 CURRENCY AND PRICING 100
2.5 DBMR TRIPOD DATA VALIDATION MODEL 101
2.6 MULTIVARIATE MODELLING 104
2.7 PRODUCT LIFELINE CURVE 105
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 106
2.9 DBMR MARKET POSITION GRID 107
2.10 VENDOR SHARE ANALYSIS 108
2.11 MARKET END USER COVERAGE GRID 109
2.12 SECONDARY SOURCES 110
2.13 ASSUMPTIONS 110
3 EXECUTIVE SUMMARY 111
4 PREMIUM INSIGHTS 116
4.1 PESTAL ANALYSIS 117
4.2 PORTERS FIVE FORCES ANALYSIS 118
4.3 INDUSTRY INSIGHTS 119
4.3.1 MICRO AND MACROECONOMIC FACTORS 119
4.3.2 PENETRATION AND GROWTH PROSPECT MAPPING 119
4.3.3 KEY PRICING STRATEGIES 119
4.3.4 COST ANALYSIS BREAKDOWN 119
4.3.5 TECHNOLOGY ROADMAP 119
4.3.6 OPPUTUNITY MAP ANALYSIS 120
4.3.7 PRICING ANALYSIS 120
4.3.8 COMPETITOR’S MODEL ANALYSIS 120
4.3.9 HEALTHCARE ECONOMY 120
4.3.9.1 HEALTHCARE EXPENDITURE 120
4.3.9.2 CAPITAL EXPENDITURE 120
4.3.9.3 CAPEX TRENDS 121
4.3.9.4 CAPEX ALLOCATION 121
4.3.9.5 FUNDING SOURCES 121
4.3.9.6 INDUSTRY BENCHMARKS 121
4.3.9.7 GDP RATIO IN OVERALL GDP 121
4.3.9.8 HEALTHCARE SYSTEM STRUCTURE 122
4.3.9.9 GOVERNMENT POLICIES 122
4.3.9.10 ECONOMIC DEVELOPMENT 122
4.4 CURRENT TARIFF RATE (S) IN TOP-5 COUNTRY MARKETS 123
4.4.1 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE 123
4.4.2 VENDOR SELECTION CRITERIA DYNAMICS 124
4.4.3 IMPACT ON SUPPLY CHAIN 124
4.4.3.1 RAW MATERIAL PROCUREMENT 125
4.4.3.2 MANUFACTURING AND PRODUCTION 125
4.4.3.3 LOGISTICS AND DISTRIBUTION 126
4.4.3.4 PRICE PITCHING AND POSITION OF MARKET 126
4.4.4 INDUSTRY PARTICIPANTS: PROACTIVE MOVES 127
4.4.4.1 SUPPLY CHAIN OPTIMIZATION 127
4.4.4.2 JOINT VENTURE ESTABLISHMENTS 128
4.4.5 IMPACT ON PRICES 129
4.4.6 REGULATORY INCLINATION 129
4.4.6.1 GEOPOLITICAL SITUATION 130
4.4.6.2 TRADE PARTNERSHIPS BETWEEN THE COUNTRIES 130
4.4.6.3 FREE TRADE AGREEMENTS 131
4.4.6.4 ALLIANCES ESTABLISHMENTS 131
4.4.6.5 STATUS ACCREDITATION (INCLUDING MFTN) 132
4.4.6.6 DOMESTIC COURSE OF CORRECTION 132
4.4.6.7 INCENTIVE SCHEMES TO BOOST PRODUCTION OUTPUTS 133
4.4.6.8 ESTABLISHMENT OF SPECIAL ECONOMIC ZONES/INDUSTRIAL PARKS 134
4.4.7 PRICE INDEX 134
4.5 INNOVATION TRACKER AND STRATEGIC ANALYSIS 135
4.6 SUPPLY CHAIN ECOSYSTEM 137
4.7 COMPANY EVALUATION QUADRANT 138
5 REGULATORY COMPLIANCE 139
5.1 REGULATORY AUTHORITIES 139
5.2 REGULATORY CLASSIFICATIONS 140
5.3 REGULATORY SUBMISSIONS 141
5.4 INTERNATIONAL HARMONIZATION 141
5.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS 141
5.6 REGULATORY CHALLENGES AND STRATEGIES 141
6 MARKET OVERVIEW 142
6.1 DRIVERS 144
6.1.1 RISING PREVALENCE OF GASTROINTESTINAL DISORDERS 144
6.1.2 AGING POPULATION DRIVING INCREASED DEMAND FOR GI ENDOSCOPY 145
6.1.3 TECHNOLOGICAL ADVANCEMENTS ENHANCING GI ENDOSCOPY PROCEDURES 146
6.1.4 RISING AWARENESS AND EXPANDED SCREENING PROGRAMS FOR GASTROINTESTINAL ENDOSCOPY 147
6.2 RESTRAINTS 148
6.2.1 HIGH COST OF EQUIPMENT AND PROCEDURES 148
6.2.2 RISK OF PROCEDURE-RELATED COMPLICATIONS 149
6.3 OPPORTUNITIES 150
6.3.1 GROWING EMPHASIS ON EARLY COLORECTAL CANCER DETECTION 150
6.3.2 GROWING ADOPTION OF HOME-BASED AND CAPSULE ENDOSCOPY SOLUTIONS 151
6.3.3 INCREASING PREVALENCE AND ADVANCEMENTS IN PERSONALIZED THERAPEUTIC ENDOSCOPY 152
6.4 CHALLENGES 153
6.4.1 LIMITED ACCESS TO GI ENDOSCOPY IN RURAL AREAS 153
6.4.2 COMPLEXITIES IN ENDOSCOPE REPROCESSING AND STERILIZATION PROCESSES 154
7 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET, BY PRODUCT 155
7.1 OVERVIEW 156
7.2 GASTROINTESTINAL ENDOSCOPES & SYSTEMS 159
7.2.1 ENDOSCOPES 161
7.2.1.1 COLONOSCOPES 162
7.2.1.2 GASTROSCOPES 162
7.2.1.3 DUODENOSCOPES 162
7.2.1.4 ENTEROSCOPES 162
7.2.1.5 SIGMOIDOSCOPES 162
7.2.1.6 RESECTOSCOPES 162
7.2.2 FLEXIBLE 163
7.2.3 RIGID 163
7.2.4 SEMI RIGID 163
7.2.4.1 VIDEO 164
7.2.4.2 FIBRE 164
7.2.4.3 ULTRASONIC 164
7.2.5 VISUALIZATION SYSTEMS 165
7.2.5.1 FLUORESCENCE IMAGING SYSTEMS 165
7.2.5.1.1 NIR LIGHT FLUORESCENCE IMAGING SYSTEM 166
7.2.5.1.2 WHITE LIGHT FLUORESCENCE IMAGING SYSTEM 166
7.2.5.1.3 UV LIGHT FLUORESCENCE IMAGING SYSTEMS 166
7.2.5.1.4 CONFOCAL LASER ENDOSCOPY IMAGING SYSTEMS 166
7.2.5.1.5 PROBE-BASED CLE (PCLE) 167
7.2.5.1.6 BUILT-IN DEVICE CLE (ECLE) 167
7.2.5.2 HIGH DEFINITION (HD) VISUALIZATION SYSTEMS 168
7.2.5.2.1 2D SYSTEMS 168
7.2.5.2.2 3D SYSTEMS 168
7.2.5.3 STANDARD DEFINITION (SD) VISUALIZATION SYSTEMS 169
7.2.5.3.1 ENDOSCOPIC ULTRASONOGRAPHY SYSTEMS 169
7.2.5.3.2 CAPSULE ENDOSCOPES 169
7.2.5.3.3 ULTRASOUND DEVICE 169
7.3 GASTROINTESTINAL ENDOTHERAPY 170
7.3.1 ERCP DEVICES 172
7.3.2 BIOPSY DEVICE 172
7.3.3 STENTING AND DILATION DEVICE 172
7.3.4 HOMEOSTASIS DEVICES 172
7.3.4.1 LIGATION DEVICES 173
7.3.4.2 PROBES 173
7.3.4.3 SCLEROTHERAPY NEEDLES 173
7.3.5 RETRIEVAL DEVICES 174
7.3.6 CAMERA HEAD 174
7.3.7 ANTI-REFLUX DEVICES 174
7.3.7.1 TRANSORAL INCISIONLESS FUNDOPLICATION (TIF) DEVICES 174
7.3.7.2 TRANSESOPHAGEAL RADIOFREQUENCY (RF) ANTI-REFLUX DEVICES 174
7.3.8 OTHERS 175
8 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET, BY PROCEDURE TYPE 176
8.1 OVERVIEW 177
8.2 COLONOSCOPY 180
8.3 GASTROSCOPY 181
8.4 DUODENOSCOPY 181
8.5 ENTEROSCOPY 182
8.6 SIGMOIDOSCOPY 182
8.7 OTHERS 183
9 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET, BY USABILITY 184
9.1 OVERVIEW 185
9.2 REUSABLE 188
9.3 DISPOSABLE/ SINGLE USE 189
10 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET, BY APPLICATION 190
10.1 OVERVIEW 191
10.2 TREATMENT 194
10.3 DIAGNOSIS 195
11 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET, BY END USER 196
11.1 OVERVIEW 197
11.2 HOSPITALS 201
11.3 AMBULATORY SURGICAL CENTERS 202
11.4 SPECIALTY CLINICS 203
11.5 LABORATORIES 203
11.6 OTHERS 204
12 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET, BY DISTRIBUTION CHANNEL 205
12.1 OVERVIEW 206
12.2 DIRECT TENDER 209
12.3 RETAIL SALES 210
12.4 OTHERS 210
13 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET, BY REGION 211
13.1 NORTH AMERICA 213
13.1.1 U.S. 229
13.1.2 CANADA 244
13.1.3 MEXICO 258
14 NORTH AMERICA GASTROINTESTINAL ENDOSCOPY MARKET: COMPANY LANDSCAPE 272
14.1 COMPANY SHARE ANALYSIS: GLOBAL 272
15 SWOT ANALYSIS 273
16 COMPANY PROFILES 274
16.1 OLYMPUS CORPORATION 274
16.1.1 COMPANY SNAPSHOT 274
16.1.2 REVENUE ANALYSIS 274
16.1.3 COMPANY SHARE ANALYSIS 275
16.1.4 PRODUCT PORTFOLIO 275
16.1.5 RECENT DEVELOPMENT/NEWS 277
16.2 FUJIFILM HOLDINGS CORPORATION 278
16.2.1 COMPANY SNAPSHOT 278
16.2.2 REVENUE ANALYSIS 278
16.2.3 COMPANY SHARE ANALYSIS 279
16.2.4 PRODUCT PORTFOLIO 279
16.2.5 RECENT DEVELOPMENTS/NEWS 280
16.3 MEDTRONIC 282
16.3.1 COMPANY SNAPSHOT 282
16.3.2 REVENUE ANALYSIS 282
16.3.3 COMPANY SHARE ANALYSIS 283
16.3.4 PRODUCT PORTFOLIO 283
16.3.5 RECENT DEVELOPMENTS/NEWS 285
16.4 JOHNSON & JOHNSON SERVICES, INC. 286
16.4.1 COMPANY SNAPSHOT 286
16.4.2 REVENUE ANALYSIS 286
16.4.3 COMPANY SHARE ANALYSIS 287
16.4.4 PRODUCT PORTFOLIO 287
16.4.5 RECENT DEVELOPMENTS 287
16.5 STRYKER 288
16.5.1 COMPANY SNAPSHOT 288
16.5.2 REVENUE ANALYSIS 288
16.5.3 COMPANY SHARE ANALYSIS 289
16.5.4 PRODUCT PORTFOLIO 289
16.5.5 RECENT DEVELOPMENT 290
16.6 AMBU AS 291
16.6.1 COMPANY SNAPSHOT 291
16.6.2 REVENUE ANALYSIS 291
16.6.3 PRODUCT PORTFOLIO 292
16.6.4 RECENT DEVELOPMENTS/NEWS 293
16.7 ANX ROBOTICS 294
16.7.1 COMPANY SNAPSHOT 294
16.7.2 PRODUCT PORTFOLIO 294
16.7.3 RECENT DEVELOPMENTS/NEWS 295
16.8 BOSTON SCIENTIFIC CORPORATION 296
16.8.1 COMPANY SNAPSHOT 296
16.8.2 REVENUE ANALYSIS 296
16.8.3 PRODUCT PORTFOLIO 297
16.8.4 RECENT DEVELOPMENT 299
16.9 CAPSOVISION, INC. 300
16.9.1 COMPANY SNAPSHOT 300
16.9.2 PRODUCT PORTFOLIO 300
16.9.3 RECENT DEVELOPMENTS/NEWS 301
16.10 CONMED CORPORATION 302
16.10.1 COMPANY SNAPSHOT 302
16.10.2 PRODUCT PORTFOLIO 303
16.10.3 RECENT DEVELOPMENTS 306
16.11 COOK 307
16.11.1 COMPANY SNAPSHOT 307
16.11.2 PRODUCT PORTFOLIO 307
16.11.3 RECENT DEVELOPMENT/NEWS 309
16.12 DAICHUAN MEDICAL 310
16.12.1 COMPANY SNAPSHOT 310
16.12.2 PRODUCT PORTFOLIO 310
16.12.3 RECENT DEVELOPMENT 310
16.13 ERBE ELEKTROMEDIZIN GMBH 311
16.13.1 COMPANY SNAPSHOT 311
16.13.2 PRODUCT PORTFOLIO 311
16.13.3 RECENT DEVELOPMENT 313
16.14 GONGJIANG ENDOSCOPY INSTRUMENTS CO., LTD 314
16.14.1 COMPANY SNAPSHOT 314
16.14.2 PRODUCT PORTFOLIO 314
16.14.3 RECENT DEVELOPMENT 314
16.15 HENRY SCHEIN, INC. 315
16.15.1 COMPANY SNAPSHOT 315
16.15.2 REVENUE ANALYSIS 315
16.15.3 PRODUCT PORTFOLIO 316
16.15.4 RECENT DEVELOPMENT 316
16.16 HOYA CORPORATION. 317
16.16.1 COMPANY SNAPSHOT 317
16.16.2 REVENUE ANALYSIS 317
16.16.3 PRODUCT PORTFOLIO 318
16.16.4 RECENT DEVELOPMENT 320
16.17 INTROMEDIC 321
16.17.1 COMPANY SNAPSHOT 321
16.17.2 PRODUCT PORTFOLIO 321
16.17.3 RECENT DEVELOPMENT 321
16.18 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD 322
16.18.1 COMPANY SNAPSHOT 322
16.18.2 PRODUCT PORTFOLIO 322
16.18.3 RECENT DEVELOPMENT 324
16.19 JINSHAN SCIENCE & TECHNOLOGY 325
16.19.1 COMPANY SNAPSHOT 325
16.19.2 PRODUCT PORTFOLIO 325
16.19.3 RECENT DEVELOPMENT/NEWS 327
16.20 KLS MARTIN GROUP 328
16.20.1 COMPANY SNAPSHOT 328
16.20.2 PRODUCT PORTFOLIO 328
16.20.3 RECENT DEVELOPMENT 330
16.21 LABORIE 331
16.21.1 COMPANY SNAPSHOT 331
16.21.2 PRODUCT PORTFOLIO 331
16.21.3 RECENT DEVELOPMENT 334
16.22 MECANMEDICAL 335
16.22.1 COMPANY SNAPSHOT 335
16.22.2 PRODUCT PORTFOLIO 335
16.22.3 RECENT DEVELOPMENT 336
16.23 MICRO-TECH ENDOSCOPY 337
16.23.1 COMPANY SNAPSHOT 337
16.23.2 PRODUCT PORTFOLIO 337
16.23.3 RECENT DEVELOPMENT 339
16.24 MITRA INDUSTRIES PVT. LTD. 340
16.24.1 COMPANY SNAPSHOT 340
16.24.2 PRODUCT PORTFOLIO 340
16.24.3 RECENT DEVELOPMENT 341
16.25 OVESCO ENDOSCOPY AG 342
16.25.1 COMPANY SNAPSHOT 342
16.25.2 PRODUCT PORTFOLIO 342
16.25.3 RECENT DEVELOPMENT 344
16.26 SHAILI ENDOSCOPY 346
16.26.1 COMPANY SNAPSHOT 346
16.26.2 PRODUCT PORTFOLIO 346
16.26.3 RECENT DEVELOPMENT 348
16.27 SMITH+NEPHEW 349
16.27.1 COMPANY SNAPSHOT 349
16.27.2 REVENUE ANALYSIS 349
16.27.3 PRODUCT PORTFOLIO 350
16.27.4 RECENT DEVELOPMENT 350
16.28 SONOSCAPE MEDICAL CORP. 351
16.28.1 COMPANY SNAPSHOT 351
16.28.2 REVENUE ANALYSIS 352
16.28.3 PRODUCT PORTFOLIO 352
16.28.4 RECENT DEVELOPMENT/NEWS 354
16.29 STERIS 355
16.29.1 COMPANY SNAPSHOT 355
16.29.2 REVENUE ANALYSIS 355
16.29.3 PRODUCT PORTFOLIO 356
16.29.4 RECENT DEVELOPMENT 357
16.30 TELEFLEX INCORPORATED. 358
16.30.1 COMPANY SNAPSHOT 358
16.30.2 REVENUE ANALYSIS 358
16.30.3 PRODUCT PORTFOLIO 359
16.30.4 RECENT DEVELOPMENT 360
17 QUESTIONNAIRE 361